Newsroom

Venclose eclipses 2018 results, patient success

Vein Therapy News

Venclose brings in $27 million Series C to market venous reflux solution

MedCity News

Venclose Closes $27 Million Series C Funding

A New RF System: Venclose’s new radiofrequency technology outperforms legacy systems

Vein Therapy News

Venclose and Viant Partner to Deliver Next-Generation Vein Treatment Solutions

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System